Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.

Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.

Item
http://www.wikidata.org/entity/Q30660667
The use of proteomics to identify novel therapeutic targets for the treatment of disease.Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine.Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes.Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry.Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma.Challenges in cancer research and multifaceted approaches for cancer biomarker quest.Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture.Autoimmune pancreatic disease: preparation of pancreatic juice for proteome analysis.
P2860

Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.

Item
http://www.wikidata.org/entity/Q30660667
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Proteomics approach in classif ...... nt kinase inhibitor, bohemine.
@ast
Proteomics approach in classif ...... nt kinase inhibitor, bohemine.
@en
type
label
Proteomics approach in classif ...... nt kinase inhibitor, bohemine.
@ast
Proteomics approach in classif ...... nt kinase inhibitor, bohemine.
@en
prefLabel
Proteomics approach in classif ...... nt kinase inhibitor, bohemine.
@ast
Proteomics approach in classif ...... nt kinase inhibitor, bohemine.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Proteomics approach in classif ...... nt kinase inhibitor, bohemine.
@en
P2093
P2860
P304
P31
P356
10.1002/1522-2683(200011)21:17<3757::AID-ELPS3757>3.0.CO;2-X
P433
P478
P577
P698